-1 ,
Facial changes with GLP-1 and GIP agonists Already begun a weight loss regimen using on a GLP-1 or GIP agonist
Does the skin look more irritated than your usual injection sites
Immunohistochemical stains and electron microscopy can be used to identify the cell type involved
This discussion should address: Your specific diabetes control needs and whether alternative medications could provide adequate glycemic management The infant's health status , as premature or medically fragile infants may warrant more conservative medication approaches Your breastfeeding goals , including whether you plan exclusive breastfeeding or combination feeding Monitoring strategies for both maternal blood sugar control and infant growth and development Contact your healthcare provider if you experience severe or persistent side effects while taking any diabetes medication during lactation, including nausea, vomiting, diarrhea, or signs of hypoglycemia (shakiness, sweating, confusion)
Troy Watson works closely with each patient to monitor their response to semaglutide GLP-1 , offering personalised guidance on managing any initial side effects, such as mild nausea or digestive changes
